Talisman PFO Amplatzer Occluder Device
Talisman PFO Amplatzer Occluder Device
The Amplatzer™ Talisman™ PFO Occluder is indicated for percutaneous transcatheter closure of a patent foramen ovale (PFO) to reduce the risk of recurrent ischemic stroke in patients, predominantly between the ages of 18 and 60 years, who have had a stroke due to a presumed paradoxical embolism, as determined by a neurologist and cardiologist following an evaluation to exclude other causes of ischemic stroke.
As the device that created the category, the Amplatzer™ PFO Occluder has sustained leadership over decades of use by pursuing clinical evidence to become the first device supported by positive PFO trial results. Today, it is the most-studied device of its kind, with over 180,000 patients treated worldwide. And Abbott clinical evidence is unmatched, thanks to the largest-ever trial for PFO closure, boasting 5,810 patient-years of data.
Testimonials
What are customers saying about our products, and services:
Doctor Fernando Orellano
The best medical devices supplier of the Caribbean region
Hospital Metropolitáno de Santiago
Super quality and technologies for cardiovascular devices
CEDIMAT Plaza de la Salud
Responsables, excelente atención y buena calidad de productos médicos.
